EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis

Obreniokibo Ibifubara Amiesimaka iD, Samuel S Allemann, Rhiannon Braund, Michael Schultz, Kristina Aluzaite

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Obreniokibo Ibifubara Amiesimaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Research Unit, Department of Medicine, Dunedin School of Medicine (DSM), University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Hospitalization, Colitis, Ulcerative, Databases, Factual, Crohn Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Medicine, DSM, University of Otago.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Inflammatory bowel disease (IBD) management entails long‐term medication therapy. Worse disease outcomes and reduced quality of life might arise from poor medication adherence (MA). This study is the first to investigate patients with IBD's adherence across Aotearoa New Zealand and its relationship with disease outcomes.

Methods

Dispensing claims data (Pharmaceutical Collection) were used to calculate (3‐ and 5‐year) adherence, using daily polypharmacy possession ratio. Using hospitalization data (National Minimum Dataset), the relationship between adherence and the numbers of hospitalizations and corticosteroid dispensings was investigated.

Results

In total, 4654 patients (53% female; 55% Crohn's disease [CD], 45% ulcerative colitis [UC]; median age‐at‐first‐dispensing, 43 years) and 3148 patients (54% female; 55% CD, 44% UC; median age‐at‐first‐dispensing, 44 years) were in the 3‐ and 5‐year cohorts, respectively. The 3‐ and 5‐year cohorts had mean 4.6 and 4.2 IBD‐related hospitalizations and 6.9 and 9.2 corticosteroid dispensings, respectively. Average adherence estimates were 77.4% (95% confidence interval: 76.9–78.0%) and 74.9% (95% confidence interval: 74.1–75.6%; 3 and 5 years), while 54% and 51% of patients, respectively, had good adherence (MA ≥ 80%). There was no correlation between adherence and the numbers of hospitalizations (Pearson's R = −.0007; P = .65 and R = −.04; P = .02 [3 and 5 years]) and corticosteroid dispensings ( R = .08; P =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HospitalizationColitis, UlcerativeDatabases, FactualCrohn DiseaseDrug MonitoringHumansNew ZealandFemaleMaleAdultMiddle AgedAdrenal Cortex HormonesInflammatory Bowel DiseasesYoung AdultQuality of LifePolypharmacyAgedAdolescent

Stichwörter der Autor:innen

Aotearoa New Zealandinflammatory bowel diseaselong‐term medication adherence

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Gastroenterology Research Unit, Department of Medicine, Dunedin School of Medicine (DSM), University of Otago, Dunedin, New Zealand.
  • Pharmaceutical Care Research Group, University of Basel, Basel, Switzerland.
  • New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand.
  • Gastroenterology Unit, Dunedin Hospital, Te Whatu Ora/Health New Zealand, Dunedin, New Zealand.

ORCID-Profile: Obreniokibo Ibifubara Amiesimaka

Förderung

  • Department of Medicine, DSM, University of Otago

Zitieren

APA

Amiesimaka, O. I., Allemann, S. S., Braund, R., Schultz, M., & Aluzaite, K. (2024). Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16069

Vancouver

Amiesimaka OI, Allemann SS, Braund R, Schultz M, Aluzaite K. Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16069

BibTeX
@article{Amiesimaka2024,
  author = {Amiesimaka, Obreniokibo Ibifubara and Allemann, Samuel S and Braund, Rhiannon and Schultz, Michael and Aluzaite, Kristina},
  title = {Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16069}
}
Kostenlos starten →